Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

Crinetics Pharmaceuticals, Inc. today announced the first patient has been dosed in the Phase 1/2 study evaluating CRN09682 in patients with metastatic or locally advanced somatostatin receptor type 2 ...

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...

Pfizer & Astellas announce US FDA approves Padcev plus Keytruda for certain patients with bladder cancer: New York Monday, November 24, 2025, 12:00 Hrs [IST] Pfizer Inc. and Astel ...

Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...

Zentalis has taken a beating in 2025 to date, as the market continues to value their pipeline as a liability rather than an ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...

The fabrication of two-dimensional covalent organic framework films with uniform thickness, ordered structure and excellent semiconducting performance directly on substrates for applications in ...

Good day, and thank you for joining us. Yesterday, we issued a press release relating to the Phase III HARMONi-6 data ...